allantoin has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 1 studies
Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanagawa, S | 1 |
| Yosikawa, Y | 1 |
| Dohi, Y | 1 |
1 other study available for allantoin and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
[Phosphate binders for therapy of hyperphosphatemia causing secondary hyperparathyroidism and renal osteodystrophy in patients with chronic renal failure].
Topics: Acetates; Acetic Acid; Allantoin; Aluminum Hydroxide; Bicarbonates; Chronic Kidney Disease-Mineral a | 1991 |